Trials / Unknown
UnknownNCT06303531
Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years
An Interventional, Single-Center, Randomized, Unblinded, Parallel-Group, Three-Arm Study to Investigate the Superiority of 12 Weeks of Oral Treatment With Ferrous Ascorbate (EBMfer) or Ferrous Fumarate (Eurofer) as Compared to Polysaccharide Iron (FeraMAX) in Hemoglobin Level Changes in Adults Aged 18 and Above With Iron Deficiency Anemia (EFFICACIOUS IRON)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 111 (estimated)
- Sponsor
- Dr. Anil K. Gupta Medicine Professional Corporation · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Iron deficiency anemia (IDA) is a widespread condition affecting many people globally. Despite the many cases of IDA, there are few studies that compare the effectiveness of different types of iron supplements with a greater emphasis on the cost of supplements and their tolerability. This study aims to conduct a comparison between different iron supplements to determine the superiority of the iron supplements Ferrous Ascorbate (EBMfer) and Ferrous Fumarate (Eurofer) over polysaccharide iron (FeraMax). This comparison will be conducted by determining the change in hemoglobin levels for participants in this trial over a 3-month period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ferrous Fumarate | Ferrous Fumarate - 300 mg |
| DIETARY_SUPPLEMENT | Polysaccharide Iron | Polysaccharide Iron - 150 mg |
| DIETARY_SUPPLEMENT | Ferrous Ascorbate | Ferrous Ascorbate - 100 mg |
Timeline
- Start date
- 2024-02-24
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2024-03-12
- Last updated
- 2024-03-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06303531. Inclusion in this directory is not an endorsement.